nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—Pain in jaw—Vincristine—sarcoma	0.0481	0.066	CcSEcCtD
Phentolamine—NISCH—Podofilox—Etoposide—sarcoma	0.0476	0.592	CbGdCrCtD
Phentolamine—NISCH—Vinblastine—Vincristine—sarcoma	0.0328	0.408	CbGdCrCtD
Phentolamine—Oral pain—Epirubicin—sarcoma	0.0273	0.0374	CcSEcCtD
Phentolamine—Oral pain—Doxorubicin—sarcoma	0.0252	0.0346	CcSEcCtD
Phentolamine—Injection site pain—Thiotepa—sarcoma	0.0216	0.0297	CcSEcCtD
Phentolamine—NISCH—mammary gland—sarcoma	0.0178	0.0928	CbGeAlD
Phentolamine—SIGMAR1—mammary gland—sarcoma	0.0103	0.054	CbGeAlD
Phentolamine—Abdominal pain upper—Mitoxantrone—sarcoma	0.0101	0.0139	CcSEcCtD
Phentolamine—NISCH—smooth muscle tissue—sarcoma	0.00953	0.0498	CbGeAlD
Phentolamine—Injection site pain—Epirubicin—sarcoma	0.00871	0.012	CcSEcCtD
Phentolamine—Acute coronary syndrome—Vincristine—sarcoma	0.00864	0.0119	CcSEcCtD
Phentolamine—Myocardial infarction—Vincristine—sarcoma	0.00859	0.0118	CcSEcCtD
Phentolamine—Acute coronary syndrome—Mitoxantrone—sarcoma	0.00841	0.0116	CcSEcCtD
Phentolamine—Myocardial infarction—Mitoxantrone—sarcoma	0.00837	0.0115	CcSEcCtD
Phentolamine—Cardiac disorder—Thiotepa—sarcoma	0.00823	0.0113	CcSEcCtD
Phentolamine—NISCH—uterus—sarcoma	0.00818	0.0427	CbGeAlD
Phentolamine—Flushing—Dactinomycin—sarcoma	0.00817	0.0112	CcSEcCtD
Phentolamine—Injection site pain—Doxorubicin—sarcoma	0.00806	0.0111	CcSEcCtD
Phentolamine—Angiopathy—Thiotepa—sarcoma	0.00805	0.0111	CcSEcCtD
Phentolamine—Mediastinal disorder—Thiotepa—sarcoma	0.008	0.011	CcSEcCtD
Phentolamine—Arrhythmia—Thiotepa—sarcoma	0.00793	0.0109	CcSEcCtD
Phentolamine—Bradycardia—Mitoxantrone—sarcoma	0.0078	0.0107	CcSEcCtD
Phentolamine—SIGMAR1—myometrium—sarcoma	0.00733	0.0383	CbGeAlD
Phentolamine—Cardiac disorder—Vincristine—sarcoma	0.0073	0.01	CcSEcCtD
Phentolamine—NISCH—tendon—sarcoma	0.00716	0.0374	CbGeAlD
Phentolamine—Angiopathy—Vincristine—sarcoma	0.00714	0.0098	CcSEcCtD
Phentolamine—Mediastinal disorder—Vincristine—sarcoma	0.00709	0.00974	CcSEcCtD
Phentolamine—Injection site reaction—Epirubicin—sarcoma	0.00707	0.00971	CcSEcCtD
Phentolamine—Acute coronary syndrome—Etoposide—sarcoma	0.007	0.00961	CcSEcCtD
Phentolamine—Myocardial infarction—Etoposide—sarcoma	0.00696	0.00956	CcSEcCtD
Phentolamine—NISCH—bone marrow—sarcoma	0.00694	0.0362	CbGeAlD
Phentolamine—Arrhythmia—Mitoxantrone—sarcoma	0.00685	0.0094	CcSEcCtD
Phentolamine—Hypertension—Thiotepa—sarcoma	0.00667	0.00916	CcSEcCtD
Phentolamine—SIGMAR1—seminal vesicle—sarcoma	0.00662	0.0346	CbGeAlD
Phentolamine—Injection site reaction—Doxorubicin—sarcoma	0.00654	0.00899	CcSEcCtD
Phentolamine—Nervous system disorder—Thiotepa—sarcoma	0.00618	0.00849	CcSEcCtD
Phentolamine—Tachycardia—Thiotepa—sarcoma	0.00615	0.00845	CcSEcCtD
Phentolamine—NISCH—testis—sarcoma	0.00593	0.031	CbGeAlD
Phentolamine—Flushing—Etoposide—sarcoma	0.00592	0.00812	CcSEcCtD
Phentolamine—Cardiac disorder—Etoposide—sarcoma	0.00592	0.00812	CcSEcCtD
Phentolamine—Hypertension—Vincristine—sarcoma	0.00591	0.00812	CcSEcCtD
Phentolamine—Angiopathy—Etoposide—sarcoma	0.00578	0.00794	CcSEcCtD
Phentolamine—Hypertension—Mitoxantrone—sarcoma	0.00576	0.00791	CcSEcCtD
Phentolamine—ADRA2C—myometrium—sarcoma	0.00576	0.0301	CbGeAlD
Phentolamine—Mediastinal disorder—Etoposide—sarcoma	0.00574	0.00789	CcSEcCtD
Phentolamine—Chest pain—Mitoxantrone—sarcoma	0.00568	0.0078	CcSEcCtD
Phentolamine—Paraesthesia—Thiotepa—sarcoma	0.00566	0.00777	CcSEcCtD
Phentolamine—NISCH—liver—sarcoma	0.00561	0.0293	CbGeAlD
Phentolamine—SIGMAR1—smooth muscle tissue—sarcoma	0.00555	0.029	CbGeAlD
Phentolamine—Nervous system disorder—Vincristine—sarcoma	0.00548	0.00753	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00544	0.00747	CcSEcCtD
Phentolamine—Pain—Thiotepa—sarcoma	0.00539	0.0074	CcSEcCtD
Phentolamine—Pain—Dactinomycin—sarcoma	0.00535	0.00735	CcSEcCtD
Phentolamine—Tachycardia—Mitoxantrone—sarcoma	0.00531	0.0073	CcSEcCtD
Phentolamine—Hypotension—Vincristine—sarcoma	0.00522	0.00717	CcSEcCtD
Phentolamine—ADRA2C—seminal vesicle—sarcoma	0.0052	0.0272	CbGeAlD
Phentolamine—ADRA1A—hematopoietic system—sarcoma	0.00519	0.0271	CbGeAlD
Phentolamine—Gastrointestinal pain—Thiotepa—sarcoma	0.00515	0.00708	CcSEcCtD
Phentolamine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00512	0.00703	CcSEcCtD
Phentolamine—Hypotension—Mitoxantrone—sarcoma	0.00509	0.00699	CcSEcCtD
Phentolamine—Paraesthesia—Vincristine—sarcoma	0.00502	0.00689	CcSEcCtD
Phentolamine—Abdominal pain—Thiotepa—sarcoma	0.00498	0.00684	CcSEcCtD
Phentolamine—Abdominal pain—Dactinomycin—sarcoma	0.00495	0.00679	CcSEcCtD
Phentolamine—Paraesthesia—Mitoxantrone—sarcoma	0.00489	0.00671	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Vincristine—sarcoma	0.00483	0.00663	CcSEcCtD
Phentolamine—Hypertension—Etoposide—sarcoma	0.00479	0.00658	CcSEcCtD
Phentolamine—SIGMAR1—cardiac atrium—sarcoma	0.00478	0.025	CbGeAlD
Phentolamine—Pain—Vincristine—sarcoma	0.00478	0.00657	CcSEcCtD
Phentolamine—SIGMAR1—uterus—sarcoma	0.00476	0.0248	CbGeAlD
Phentolamine—Chest pain—Etoposide—sarcoma	0.00472	0.00649	CcSEcCtD
Phentolamine—Abdominal pain upper—Epirubicin—sarcoma	0.00472	0.00648	CcSEcCtD
Phentolamine—Orthostatic hypotension—Epirubicin—sarcoma	0.00472	0.00648	CcSEcCtD
Phentolamine—Pain—Mitoxantrone—sarcoma	0.00466	0.00639	CcSEcCtD
Phentolamine—ADRA2A—myometrium—sarcoma	0.00459	0.024	CbGeAlD
Phentolamine—Gastrointestinal pain—Vincristine—sarcoma	0.00457	0.00628	CcSEcCtD
Phentolamine—Asthenia—Thiotepa—sarcoma	0.00452	0.00621	CcSEcCtD
Phentolamine—Asthenia—Dactinomycin—sarcoma	0.00449	0.00617	CcSEcCtD
Phentolamine—Pruritus—Thiotepa—sarcoma	0.00446	0.00613	CcSEcCtD
Phentolamine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00445	0.00611	CcSEcCtD
Phentolamine—Tachycardia—Etoposide—sarcoma	0.00442	0.00607	CcSEcCtD
Phentolamine—Abdominal pain—Vincristine—sarcoma	0.00442	0.00607	CcSEcCtD
Phentolamine—Abdominal pain upper—Doxorubicin—sarcoma	0.00436	0.00599	CcSEcCtD
Phentolamine—Orthostatic hypotension—Doxorubicin—sarcoma	0.00436	0.00599	CcSEcCtD
Phentolamine—Angina pectoris—Epirubicin—sarcoma	0.00435	0.00597	CcSEcCtD
Phentolamine—Diarrhoea—Thiotepa—sarcoma	0.00431	0.00592	CcSEcCtD
Phentolamine—Abdominal pain—Mitoxantrone—sarcoma	0.0043	0.00591	CcSEcCtD
Phentolamine—NISCH—lymph node—sarcoma	0.0043	0.0224	CbGeAlD
Phentolamine—Diarrhoea—Dactinomycin—sarcoma	0.00428	0.00588	CcSEcCtD
Phentolamine—Hypotension—Etoposide—sarcoma	0.00423	0.00581	CcSEcCtD
Phentolamine—Dizziness—Thiotepa—sarcoma	0.00417	0.00573	CcSEcCtD
Phentolamine—SIGMAR1—tendon—sarcoma	0.00417	0.0218	CbGeAlD
Phentolamine—ADRA2A—seminal vesicle—sarcoma	0.00415	0.0217	CbGeAlD
Phentolamine—Paraesthesia—Etoposide—sarcoma	0.00407	0.00558	CcSEcCtD
Phentolamine—SIGMAR1—bone marrow—sarcoma	0.00404	0.0211	CbGeAlD
Phentolamine—Angina pectoris—Doxorubicin—sarcoma	0.00402	0.00553	CcSEcCtD
Phentolamine—Asthenia—Vincristine—sarcoma	0.00401	0.00551	CcSEcCtD
Phentolamine—Vomiting—Thiotepa—sarcoma	0.00401	0.0055	CcSEcCtD
Phentolamine—Vomiting—Dactinomycin—sarcoma	0.00398	0.00546	CcSEcCtD
Phentolamine—Headache—Thiotepa—sarcoma	0.00395	0.00542	CcSEcCtD
Phentolamine—ADRA2A—hematopoietic system—sarcoma	0.00395	0.0206	CbGeAlD
Phentolamine—Gastrointestinal disorder—Etoposide—sarcoma	0.00391	0.00537	CcSEcCtD
Phentolamine—Asthenia—Mitoxantrone—sarcoma	0.00391	0.00536	CcSEcCtD
Phentolamine—Pain—Etoposide—sarcoma	0.00387	0.00532	CcSEcCtD
Phentolamine—Diarrhoea—Vincristine—sarcoma	0.00382	0.00525	CcSEcCtD
Phentolamine—ADRA2A—connective tissue—sarcoma	0.0038	0.0198	CbGeAlD
Phentolamine—ADRA2C—cardiac atrium—sarcoma	0.00375	0.0196	CbGeAlD
Phentolamine—Nausea—Thiotepa—sarcoma	0.00374	0.00514	CcSEcCtD
Phentolamine—ADRA2C—uterus—sarcoma	0.00373	0.0195	CbGeAlD
Phentolamine—Diarrhoea—Mitoxantrone—sarcoma	0.00372	0.00512	CcSEcCtD
Phentolamine—Nausea—Dactinomycin—sarcoma	0.00372	0.0051	CcSEcCtD
Phentolamine—Gastrointestinal pain—Etoposide—sarcoma	0.0037	0.00509	CcSEcCtD
Phentolamine—Dizziness—Vincristine—sarcoma	0.0037	0.00508	CcSEcCtD
Phentolamine—ADRA1A—lymphoid tissue—sarcoma	0.00365	0.0191	CbGeAlD
Phentolamine—Bradycardia—Epirubicin—sarcoma	0.00364	0.005	CcSEcCtD
Phentolamine—Abdominal pain—Etoposide—sarcoma	0.00358	0.00492	CcSEcCtD
Phentolamine—Vomiting—Vincristine—sarcoma	0.00355	0.00488	CcSEcCtD
Phentolamine—Headache—Vincristine—sarcoma	0.0035	0.00481	CcSEcCtD
Phentolamine—Vomiting—Mitoxantrone—sarcoma	0.00346	0.00475	CcSEcCtD
Phentolamine—SIGMAR1—testis—sarcoma	0.00345	0.018	CbGeAlD
Phentolamine—Headache—Mitoxantrone—sarcoma	0.00341	0.00468	CcSEcCtD
Phentolamine—Bradycardia—Doxorubicin—sarcoma	0.00337	0.00462	CcSEcCtD
Phentolamine—Nausea—Vincristine—sarcoma	0.00332	0.00456	CcSEcCtD
Phentolamine—Flushing—Epirubicin—sarcoma	0.00332	0.00455	CcSEcCtD
Phentolamine—Cardiac disorder—Epirubicin—sarcoma	0.00332	0.00455	CcSEcCtD
Phentolamine—ADRA2C—tendon—sarcoma	0.00327	0.0171	CbGeAlD
Phentolamine—SIGMAR1—liver—sarcoma	0.00326	0.017	CbGeAlD
Phentolamine—Asthenia—Etoposide—sarcoma	0.00325	0.00446	CcSEcCtD
Phentolamine—Angiopathy—Epirubicin—sarcoma	0.00324	0.00445	CcSEcCtD
Phentolamine—Nausea—Mitoxantrone—sarcoma	0.00323	0.00444	CcSEcCtD
Phentolamine—Mediastinal disorder—Epirubicin—sarcoma	0.00322	0.00442	CcSEcCtD
Phentolamine—Pruritus—Etoposide—sarcoma	0.0032	0.0044	CcSEcCtD
Phentolamine—Arrhythmia—Epirubicin—sarcoma	0.00319	0.00438	CcSEcCtD
Phentolamine—Diarrhoea—Etoposide—sarcoma	0.0031	0.00426	CcSEcCtD
Phentolamine—Cardiac disorder—Doxorubicin—sarcoma	0.00307	0.00421	CcSEcCtD
Phentolamine—Flushing—Doxorubicin—sarcoma	0.00307	0.00421	CcSEcCtD
Phentolamine—Angiopathy—Doxorubicin—sarcoma	0.003	0.00412	CcSEcCtD
Phentolamine—ADRA2A—cardiac atrium—sarcoma	0.003	0.0156	CbGeAlD
Phentolamine—Dizziness—Etoposide—sarcoma	0.00299	0.00411	CcSEcCtD
Phentolamine—ADRA2A—uterus—sarcoma	0.00298	0.0156	CbGeAlD
Phentolamine—Mediastinal disorder—Doxorubicin—sarcoma	0.00298	0.00409	CcSEcCtD
Phentolamine—Arrhythmia—Doxorubicin—sarcoma	0.00295	0.00406	CcSEcCtD
Phentolamine—Vomiting—Etoposide—sarcoma	0.00288	0.00395	CcSEcCtD
Phentolamine—Headache—Etoposide—sarcoma	0.00284	0.0039	CcSEcCtD
Phentolamine—ADRA2C—testis—sarcoma	0.00271	0.0141	CbGeAlD
Phentolamine—Nausea—Etoposide—sarcoma	0.00269	0.00369	CcSEcCtD
Phentolamine—ADRA1A—liver—sarcoma	0.00269	0.014	CbGeAlD
Phentolamine—Hypertension—Epirubicin—sarcoma	0.00269	0.00369	CcSEcCtD
Phentolamine—Chest pain—Epirubicin—sarcoma	0.00265	0.00364	CcSEcCtD
Phentolamine—ADRA2A—tendon—sarcoma	0.00261	0.0136	CbGeAlD
Phentolamine—ADRA2C—liver—sarcoma	0.00256	0.0134	CbGeAlD
Phentolamine—SIGMAR1—lymph node—sarcoma	0.0025	0.0131	CbGeAlD
Phentolamine—Nervous system disorder—Epirubicin—sarcoma	0.00249	0.00342	CcSEcCtD
Phentolamine—Hypertension—Doxorubicin—sarcoma	0.00248	0.00341	CcSEcCtD
Phentolamine—Tachycardia—Epirubicin—sarcoma	0.00248	0.0034	CcSEcCtD
Phentolamine—Chest pain—Doxorubicin—sarcoma	0.00245	0.00336	CcSEcCtD
Phentolamine—Hypotension—Epirubicin—sarcoma	0.00237	0.00326	CcSEcCtD
Phentolamine—Nervous system disorder—Doxorubicin—sarcoma	0.0023	0.00316	CcSEcCtD
Phentolamine—Tachycardia—Doxorubicin—sarcoma	0.00229	0.00315	CcSEcCtD
Phentolamine—Paraesthesia—Epirubicin—sarcoma	0.00228	0.00313	CcSEcCtD
Phentolamine—Hypotension—Doxorubicin—sarcoma	0.00219	0.00301	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Epirubicin—sarcoma	0.00219	0.00301	CcSEcCtD
Phentolamine—Pain—Epirubicin—sarcoma	0.00217	0.00298	CcSEcCtD
Phentolamine—ADRA2A—testis—sarcoma	0.00216	0.0113	CbGeAlD
Phentolamine—Paraesthesia—Doxorubicin—sarcoma	0.00211	0.0029	CcSEcCtD
Phentolamine—Gastrointestinal pain—Epirubicin—sarcoma	0.00208	0.00285	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00203	0.00278	CcSEcCtD
Phentolamine—Pain—Doxorubicin—sarcoma	0.00201	0.00276	CcSEcCtD
Phentolamine—Abdominal pain—Epirubicin—sarcoma	0.00201	0.00276	CcSEcCtD
Phentolamine—ADRA2C—lymph node—sarcoma	0.00196	0.0103	CbGeAlD
Phentolamine—Gastrointestinal pain—Doxorubicin—sarcoma	0.00192	0.00264	CcSEcCtD
Phentolamine—Abdominal pain—Doxorubicin—sarcoma	0.00186	0.00255	CcSEcCtD
Phentolamine—Asthenia—Epirubicin—sarcoma	0.00182	0.0025	CcSEcCtD
Phentolamine—Pruritus—Epirubicin—sarcoma	0.0018	0.00247	CcSEcCtD
Phentolamine—Diarrhoea—Epirubicin—sarcoma	0.00174	0.00239	CcSEcCtD
Phentolamine—Asthenia—Doxorubicin—sarcoma	0.00169	0.00231	CcSEcCtD
Phentolamine—Dizziness—Epirubicin—sarcoma	0.00168	0.00231	CcSEcCtD
Phentolamine—Pruritus—Doxorubicin—sarcoma	0.00166	0.00228	CcSEcCtD
Phentolamine—Vomiting—Epirubicin—sarcoma	0.00161	0.00222	CcSEcCtD
Phentolamine—Diarrhoea—Doxorubicin—sarcoma	0.00161	0.00221	CcSEcCtD
Phentolamine—Headache—Epirubicin—sarcoma	0.00159	0.00218	CcSEcCtD
Phentolamine—ADRA2A—lymph node—sarcoma	0.00157	0.00818	CbGeAlD
Phentolamine—Dizziness—Doxorubicin—sarcoma	0.00155	0.00213	CcSEcCtD
Phentolamine—Nausea—Epirubicin—sarcoma	0.00151	0.00207	CcSEcCtD
Phentolamine—Vomiting—Doxorubicin—sarcoma	0.00149	0.00205	CcSEcCtD
Phentolamine—Headache—Doxorubicin—sarcoma	0.00147	0.00202	CcSEcCtD
Phentolamine—Nausea—Doxorubicin—sarcoma	0.0014	0.00192	CcSEcCtD
